Skip to main content
Account

Peer review reports

From: Rituximab for the treatment of relapsing-remitting multiple sclerosis in Thailand: an economic evaluation and budget impact analysis

Original Submission
19 Apr 2023 Submitted Original manuscript
21 Apr 2023 Author responded Author comments - Usa Chaikledkaew
Resubmission - Version 2
21 Apr 2023 Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
7 Jun 2023 Reviewed Reviewer Report
10 Jun 2023 Reviewed Reviewer Report
30 Jul 2023 Author responded Author comments - Usa Chaikledkaew
Resubmission - Version 5
30 Jul 2023 Submitted Manuscript version 5
2 Aug 2023 Author responded Author comments - Usa Chaikledkaew
Resubmission - Version 6
2 Aug 2023 Submitted Manuscript version 6
15 Aug 2023 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
1 Oct 2023 Editorially accepted
13 Oct 2023 Article published 10.1186/s12913-023-10099-1

Learn about peer review

Back to article page

Navigation